INVO Fertility (IVF) stock has surged 215% recently, reaching a valuation of $6.52 million. This rise lacks fundamental support, suggesting potential price manipulation. The sudden increase mirrors meme stock rallies driven by social media speculation. However, caution is advised as historically, such parabolic surges end in sharp corrections and losses for investors.

IVF’s history is marked by instability, including unprofitability, cash flow issues, and reverse stock splits. A brief merger with Naya Biosciences was quickly undone, highlighting the company’s turbulent past. With high cash burn and a track record of diluting shareholders, the risk of total loss is significant at current inflated levels. The stock’s overbought RSI signals a potential pullback ahead.

Investing in INVO Fertility comes with substantial risk due to lack of analyst coverage and a history of financial challenges. The stock’s overbought conditions and potential for sharp corrections make it a risky bet for 2026. Proceed with caution and consider the company’s unstable past before making any investment decisions.

Read more at Yahoo Finance: This Little-Known Fertility Stock Is Up 215% in the Past 5 Days. Should You Chase the Mysterious Penny Stock Rally Here?